Sharapova fights back over ‘distorted’ reporting of doping case

 The five-time grand slam winner, who faces a suspension of up to four years, claims the communications from tennis authorities about changes to drugs on the banned list were “too hard to find.”

Sharapova said she had been taking the heart drug since 2006 but dismissed reports she took it every day, saying she followed doctors’ instructions and took it in the “low doses recommended.”

Reports this week suggested the normal course of treatment for patients on meldonium, sometimes known as mildronate, is four to six weeks.

“That headline has been repeated by many reporters who fail to tell their viewers and readers what the rest of the story says,” wrote Sharapova.

“The story quotes the manufacturer of my medicine as saying: ‘Treatment course can be repeated twice or thrice a year. Only physicians can follow and evaluate patient’s health condition and state whether the patient should use meldonium for a longer period of time.’

“That’s exactly what I did. I didn’t take the medicine every day.”

‘Wrong’

“A report said that I had been warned five times about the upcoming ban on the medicine I was taking,” she wrote. “That is not true and it never happened.”

Sharapova said the way the International Tennis Federation, the sport’s governing body, informed players of the changes were “buried in newsletters, websites, or handouts.”

Sharapova failed a drug test on January 26 after losing to Serena Williams in the quarterfinals of the Australian Open. She was charged with an anti-doping violation on March 2, and was provisionally banned from March 12.

The ban could be reduced to two years or less if anti-doping officials find Sharapova did not intentionally take the drug to enhance performance.